These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 3348795)
1. Haloketone transition state analog inhibitors of cholesterol esterase. Sohl J; Sutton LD; Burton DJ; Quinn DM Biochem Biophys Res Commun; 1988 Feb; 151(1):554-60. PubMed ID: 3348795 [TBL] [Abstract][Full Text] [Related]
2. p-Nitrophenyl and cholesteryl-N-alkyl carbamates as inhibitors of cholesterol esterase. Hosie L; Sutton LD; Quinn DM J Biol Chem; 1987 Jan; 262(1):260-4. PubMed ID: 3793726 [TBL] [Abstract][Full Text] [Related]
3. The nature of the inhibition of cholesterol esterase by delta 1-tetrahydrocannabinol. Shoupe TS; Hunter SA; Burstein SH; Hubbard CD Enzyme; 1980; 25(2):87-91. PubMed ID: 6247150 [TBL] [Abstract][Full Text] [Related]
5. Dimensional mapping of the active site of cholesterol esterase with alkylboronic acid inhibitors. Sutton LD; Lantz JL; Eibes T; Quinn DM Biochim Biophys Acta; 1990 Oct; 1041(1):79-82. PubMed ID: 2223850 [TBL] [Abstract][Full Text] [Related]
6. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase. Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704 [TBL] [Abstract][Full Text] [Related]
7. Molecular recognition by cholesterol esterase of active site ligands: structure-reactivity effects for inhibition by aryl carbamates and subsequent carbamylenzyme turnover. Feaster SR; Lee K; Baker N; Hui DY; Quinn DM Biochemistry; 1996 Dec; 35(51):16723-34. PubMed ID: 8988009 [TBL] [Abstract][Full Text] [Related]
8. Inhibitors of sterol synthesis. Oleate ester of 5 alpha-cholest-8(14)-en-3 beta-ol-15-one as a substrate for pancreatic cholesterol esterase. Stephens TW; Schroepfer GJ Biochim Biophys Acta; 1988 Dec; 963(3):395-400. PubMed ID: 3196743 [TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of cholesterol esterase from porcine pancreas. Momsen WE; Brockman HL Biochim Biophys Acta; 1976 Jan; 486(1):103-13. PubMed ID: 12831 [TBL] [Abstract][Full Text] [Related]
10. Quantitative structure-activity relationships for the pre-steady-state inhibition of cholesterol esterase by 4-nitrophenyl-N-substituted carbamates. Lin G; Liao WC; Chiou SY Bioorg Med Chem; 2000 Nov; 8(11):2601-7. PubMed ID: 11092545 [TBL] [Abstract][Full Text] [Related]
17. Use of ab initio calculations to predict the biological potency of carboxylesterase inhibitors. Wheelock CE; Colvin ME; Uemura I; Olmstead MM; Sanborn JR; Nakagawa Y; Jones AD; Hammock BD J Med Chem; 2002 Dec; 45(25):5576-93. PubMed ID: 12459025 [TBL] [Abstract][Full Text] [Related]
18. Characterization of steroid hormone ester hydrolyzing enzymes in liver microsomes. Hattori K; Kamio M; Nakajima E; Oshima T; Satoh T; Kitagawa H Biochem Pharmacol; 1981 Aug; 30(15):2051-6. PubMed ID: 7295325 [No Abstract] [Full Text] [Related]
19. [The effect of cholesterol esterase on low density lipoproteins. The effect of modified lipoproteins on the accumulation of cholesterol in cultured cells]. Kovaleva GG; Karmanskiĭ IM Vopr Med Khim; 1989; 35(3):47-51. PubMed ID: 2773384 [TBL] [Abstract][Full Text] [Related]
20. Enantiomeric inhibitors of cholesterol esterase and acetylcholinesterase. Lin G; Tsai YC; Liu HC; Liao WC; Chang CH Biochim Biophys Acta; 1998 Oct; 1388(1):161-74. PubMed ID: 9774723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]